A Phase II Trial of Ganetespib: Efficacy and Safety in Patients (pts) with Metastatic Breast Cancer (MBC)

被引：3
|
作者：
Jhaveri, K. [1 ]
Chandarlapaty, S. [1 ]
Lake, D. [1 ]
Gilewski, T. [1 ]
Drullinsky, P. [1 ]
Sugarman, S. [1 ]
Wasserheit-Leiblich, C. [1 ]
Moynahan, M. E. [1 ]
D'Andrea, G. [1 ]
Haque, S. [1 ]
Patil, S. [1 ]
Bauman, L. [1 ]
Vukovic, V. [1 ]
El-Hariry, I. [1 ]
Hudis, C. [1 ]
Modi, S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P1-17-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-17-08
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cardiac safety in patients (pts) with metastatic breast cancer (MBC) treated with lapatinib (L) and trastuzumab (TRA)
    Storniolo, A. M.
    Koehler, M.
    Preston, A.
    Rappold, E.
    Byrne, J.
    Ewer, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer MBC
    Bensalem, A
    Bouzid, K
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 1) : S21 - S21
  • [23] Phase II clinical trial of ixabepilone in metastatic breast cancer (MBC) patients previously untreated with taxanes.
    Denduluri, N.
    Lee, J. J.
    Walshe, J. M.
    Yang, S. X.
    Vatas, U.
    Chow, C. K.
    Steinberg, S. M.
    Cox, M. C.
    Low, J. A.
    Swain, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 40S - 40S
  • [24] MULTICENTER, PHASE II STUDY OF LAROTAXEL IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC) PROGRESSING AFTER ANTHRACYCLINES, TAXANES AND CAPECITABINE
    Ozguroglu, M.
    Mansutti, M.
    Kerr, R.
    Awada, A.
    Rha, S. Y.
    Im, Y. H.
    Perez Manga, G.
    Germann, N.
    Fumoleau, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 69 - 69
  • [25] A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
    A Bensalem
    K Bouzid
    Breast Cancer Research, 7
  • [26] A phase 2 study of HER3-DXd in patients (pts) with metastatic breast cancer (MBC)
    Hamilton, Erika P.
    Dosunmu, Ololade
    Shastry, Mythili
    Finney, Lindsey
    Sellami, Dalila B.
    Sternberg, David W.
    Wright-Browne, Vance
    Toppmeyer, Deborah
    Gwin, William R.
    Thaddeus, J. Thaddeus
    Cultrera, Jennifer L.
    Bagegni, Nusayba Ali
    Khoury, Katia
    Heeke, Arielle Lutterman
    Yuan, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Mitoxantrone and methotrexate (MM) in elderly patients (pts) with metastatic breast cancer (MBC)
    van Veelen, H
    Tjabbes, T
    Bong, SB
    Piersma, H
    Runhaar, EA
    Vermeer, RJ
    Scholtens, T
    ANNALS OF ONCOLOGY, 1998, 9 : 20 - 20
  • [28] Phase II trial of ixabepilone (Ixa) and dasatinib (D) for treatment of metastatic breast cancer (MBC)
    Schwartzberg, L. S.
    Tauer, K. W.
    Schnell, F. M.
    Hermann, R.
    Rubin, P.
    Christianson, D.
    Weinstein, P.
    Epperson, A.
    Walker, M.
    CANCER RESEARCH, 2012, 72
  • [29] Safety profile of docetaxel in patients (pts) ≥65 years of age with metastatic breast cancer (MBC): Analysis of four phase III studies
    Hurria, Arti
    Jones, Stephen
    Olsen, Steven
    Murawsky, Michael
    Tsai, Kao-Tai
    Alakl, May
    Aapro, Matti
    ANNALS OF ONCOLOGY, 2004, 15 : 47 - 47
  • [30] A phase II pilot study of vinorelbine and cisplatin in patients with metastatic breast cancer (MBC)
    Abraham, J
    McAdam, K
    Wilson, CB
    Earl, HM
    BRITISH JOURNAL OF CANCER, 2001, 85 : 51 - 51
12345